Back to Search
ALBERT LOCKHART, MD
MD
Medical Oncology Physician
NPI: 1437233533IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
ME133041(FL)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
2008011071(MO)85559(SC)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Class of 1993
Research & Publications (20)
PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis.
PMID 17698496·Brain·2007
8-other
A new hemostatic agent: initial life-saving experience with Celox (chitosan) in cardiothoracic surgery.
PMID 19161732·Ann Thorac Surg·2009
5-case
A phase I dose-escalation study of SR271425, an intravenously dosed thioxanthone analog, administered weekly in patients with refractory solid tumors.
PMID 19194116·Am J Clin Oncol·2009
3-trial
Novel targets in esophageal and gastric cancer: beyond antiangiogenesis.
PMID 19642951·Expert Opin Investig Drugs·2009
6-review
Administration of oxaliplatin to a pregnant woman with rectal cancer.
PMID 18357450·Cancer Chemother Pharmacol·2009
5-case
Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies.
PMID 19226369·J Neurochem·2009
4-observational
Monitoring the amyloid beta-peptide in vivo--caveat emptor.
PMID 19135168·Drug Discov Today·2009
6-review
Phase II trial of T138067, a novel microtubule inhibitor, in patients with metastatic, refractory colorectal carcinoma.
PMID 18279576·Clin Colorectal Cancer·2008
3-trial
In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain.
PMID 18221373·J Neurochem·2008
4-observational
Overexpression of OATP1B3 confers apoptotic resistance in colon cancer.
PMID 19074900·Cancer Res·2008
8-other
Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancer.
PMID 18463792·Invest New Drugs·2008
3-trial
Discovering oxysterols in plasma: a window on the metabolome.
PMID 18605750·J Proteome Res·2008
8-other
A phase I trial of irinotecan alternating with epirubicin in patients with advanced malignancies.
PMID 18838875·Am J Clin Oncol·2008
3-trial
A phase I trial of CEP-701 + gemcitabine in patients with advanced adenocarcinoma of the pancreas.
PMID 18217204·Invest New Drugs·2008
3-trial
A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer.
PMID 17516069·Cancer Chemother Pharmacol·2008
3-trial
A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
PMID 17881149·Int J Radiat Oncol Biol Phys·2008
3-trial
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.
PMID 17947727·J Clin Oncol·2007
3-trial
Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors.
PMID 17091249·Cancer Chemother Pharmacol·2007
3-trial
Characterisation of the binding of amyloid imaging tracers to rodent Abeta fibrils and rodent-human Abeta co-polymers.
PMID 16842745·Biochem Biophys Res Commun·2006
7-preclinical
Imaging Alzheimer's disease pathology: one target, many ligands.
PMID 17129828·Drug Discov Today·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 171 ASHLEY AVE
CHARLESTON, SC 29425 - Phone
- (843) 792-1414
Quick Facts
- NPI
- 1437233533
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile